C12R 2001/39
Pseudomonas fluorescens
C12R2001/39 (Pseudomonas fluorescens) appears on 91 US grants and 85 published applications in this corpus.
Search patents in C12R- Granted patents
- 91
- Published applications
- 85
- Assignees
- 77
- Inventors
- 227
- Latest grant
- 25 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 4 | 0 |
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 3 | 0 |
| 1984 | 3 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 2 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 3 | 0 |
| 1995 | 0 | 0 |
| 1996 | 2 | 0 |
| 1997 | 6 | 0 |
| 1998 | 6 | 0 |
| 1999 | 3 | 0 |
| 2000 | 1 | 0 |
| 2001 | 2 | 0 |
| 2002 | 2 | 0 |
| 2003 | 1 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 0 | 2 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 1 | 2 |
| 2010 | 1 | 2 |
| 2011 | 0 | 2 |
| 2012 | 1 | 1 |
| 2013 | 0 | 0 |
| 2014 | 2 | 1 |
| 2015 | 0 | 7 |
| 2016 | 1 | 5 |
| 2017 | 9 | 6 |
| 2018 | 1 | 4 |
| 2019 | 5 | 7 |
| 2020 | 6 | 8 |
| 2021 | 3 | 3 |
| 2022 | 2 | 4 |
| 2023 | 4 | 12 |
| 2024 | 4 | 10 |
| 2025 | 6 | 4 |
| 2026 | 0 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Method for preparing (s)-1,2,3,4-tetrahydroisoquinoline-1 carboxylic acid and derivatives thereof25 Nov 2025US 12,480,148 B2Tongli Biomedical Co., Ltd.
- Microbes, compositions, and uses for increasing plant yield and/or drought tolerance16 Sep 2025US 12,414,568 B2Pro Farm Group, Inc.
- Modified biological control agents and their uses26 Aug 2025US 12,398,364 B2Certis USA, L.L.C.
- Treatment of parasitic infections of fish surfaces1 Jul 2025US 12,344,836 B2Nederlands Instituut voor Ecologie (Nioo-Knaw)
- Pseudomonas fluorescens N1 and use thereof13 May 2025US 12,297,424 B2Shanxi Boyu Biotechnology Co., Ltd.
- Lower airway probiotics and methods of use for protection and treatment of respiratory disease16 Jul 2026US 2026/0199406 A1National Technology & Engineering Solutions of Sandia, LLC
- Methods for expression of fusion-free bovine ultralong cdr3 scaffold16 Jul 2026US 2026/0201020 A1Pelican Technology Holdings, Inc.
- Cells and method for producing rhamnolipids using alternative glucose transporters16 Jul 2026US 2026/0201431 A1Evonik Operations GmbH
- Bacterial composition and method for inoculation14 May 2026US 2026/0132371 A1El-I Technologies (Pty) Limited
- Modified Biological Control Agents and Their Uses30 Oct 2025US 2025/0333689 A1Certis USA, L.L.C.
Most cited
By later US patents
- Sewage and contamination remediation and materials for effecting same36US 5,531,898 AInternational Organic Solutions Corp. · 1996
- Anti-pathogenic bacterial strains of Pseudomonas fluorescens34US 5,348,742 ACiba-Geigy Corporation · 1994
- Recombinant nitrogen-fixing bacterial strain, inoculum containing the same and application methods34US 9,657,298 B2Consejo Nacional De Investigaciones Cientificas Y Tecnicas (Conicet) · 2017
- DNA encoding the pseudomonas fluorescens sensor/kinase element, lemA, and its use in activating gene expression31US 5,686,282 ANovartis Finance Corporation · 1997
- Waste site reclamation with recovery of radionuclides and metals30US 5,292,456 AAssociated Universities, Inc. · 1994